Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice

International Immunopharmacology

Volumn 12, Issue 1, 2012, Pages 125-130

  Yu, Zhijian ^a   Huang, Zhen ^a   Sao, Chongwen ^b   Huang, Yuanjian ^b   Zhang, Fan ^a   Yang, Jin ^a   Lian, Jie ^a   Zeng, Zhongming ^a   Luo, Wenshen ^c   Zeng, Weiseng ^a   Deng, Qiwen ^a  

^a The 6th Affiliated Hospital of Shenzhen University Health Science Center   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bifidobacterium; Coxsackie virus B3; Enterovirus; Interleukin 12; Myocarditis; Oral administration

Indexed keywords

ARABINOSE; BACTERIAL VECTOR; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIFIDOBACTERIUM LONGUM; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ENGINEERING; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; VIRUS LOAD; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; BIFIDOBACTERIUM; COXSACKIEVIRUS INFECTIONS; DRUG CARRIERS; FECES; INTERFERON-GAMMA; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFORMATION, BACTERIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856113930     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.10.022     Document Type: Article

References (23)

1. J.R. Rodriguez-Madoz, K.H. Liu, J.I. Quetglas, M. Ruiz-Guillen, I. Otano, J. Crettaz, S.D. Butler, C.A. Bellezza, N.L. Dykes, B.C. Tennant, J. Prieto, G. González-Aseguinolaza, C. Smerdou, and S. Menne Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma J Virol 83 23 2009 12266 12278
2. S. Ruan, L. McKinley, M. Zheng, X. Rudner, A. D'Souza, J.K. Kolls, and J.E. Shellito Interleukin-12 and host defense against murine Pneumocystis pneumonia Infect Immun 76 5 2008 2130 2137 (Pubitemid 351656147)
3. Y. Hama, M. Kurokawa, M. Imakita, Y. Yoshida, T. Shimizu, W. Watanabe, and K. Shiraki Interleukin 12 is a primary cytokine responding to influenza virus infection in the respiratory tract of mice Acta Virol 53 4 2009 233 240
4. Y. Wang, G. Chaudhri, R.J. Jackson, and G. Karupiah IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection J Immunol 183 5 2009 3324 3331
5. P. Berraondo, J. Prieto, and G. Gonzalez-Aseguinolaza Advances in interleukin-12 gene therapy for acquired liver diseases Curr Gene Ther 9 2 2009 62 71
6. P. Kapil, R. Atkinson, C. Ramakrishna, D.J. Cua, C.C. Bergmann, and S.A. Stohlman Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control J Virol 83 12 2009 5978 5986
7. E.I. Rigopoulou, D. Suri, S. Chokshi, I. Mullerova, S. Rice, R.S. Tedder, R. Williams, and N.V. Naoumov Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity Hepatology 42 5 2005 1028 1036 (Pubitemid 43112669)
8. B.T. Seet, J.B. Johnston, C.R. Brunetti, J.W. Barrett, H. Everett, C. Cameron, J. Sypula, S.H. Nazarian, A. Lucas, and G. McFadden Poxviruses and immune evasion Annu Rev Immunol 21 2003 377 423 (Pubitemid 37174536)
9. M.M. Stanford, J.W. Barrett, P.A. Gilbert, R. Bankert, and G. McFadden Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits J Virol 81 22 2007 12704 12708 (Pubitemid 350085886)
10. D. Nolt, and J.L. Flynn Interleukin-12 therapy reduces the number of immune cells and pathology in lungs of mice infected with Mycobacterium tuberculosis Infect Immun 72 5 2004 2976 2988 (Pubitemid 38542428)
11. D. Fairweather, S. Yusung, S. Frisancho, M. Barrett, S. Gatewood, R. Steele, and N.R. Rose IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication J Immunol 170 9 2003 4731 4737 (Pubitemid 36519981)
12. D.M. Potvin, D.W. Metzger, W.T. Lee, D.N. Collins, and A.I. Ramsingh Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4 J Virol 77 15 2003 8272 8279 (Pubitemid 36871455)
13. A.L. Elías-López, B. Marquina, A. Gutiérrez-Ortega, D. Aguilar, M. Gomez-Lim, and R. Hernández-Pando Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis Clin Exp Immunol 154 1 2008 123 133
14. C.M. Salvatore, M. Fonseca-Aten, K. Katz-Gaynor, A.M. Gomez, and R.D. Hardy Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia Infect Immun 76 2 2008 732 738 (Pubitemid 351251745)
15. X. Li, G.F. Fu, Y.R. Fan, W.H. Liu, X.J. Liu, J.J. Wang, and G.X. Xu Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth Cancer Gene Ther 10 2003 105 111 (Pubitemid 36228257)
16. M.L.R. Escogido, A.D.L. RodrÍguez, and A.P.B. de la Rosa A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum Biotechnol Lett 29 2007 1249 1253
17. G.S. Moon, Y.R. Pyun, M.S. Park, G.E. Ji, and W.J. Kim Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for bifidobacterial α-amylase Appl Environ Microbiol 72 2005 5630 5632 (Pubitemid 41338308)
18. R.T. Long, W.S. Zeng, L.Y. Chen, J. Guo, Y.Z. Lin, Q.S. Huang, and S.Q. Luo Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice Int J Obes (Lond) 34 4 2010 712 719
19. J. Yao, J.Y. Wang, M.G. Lai, Y.X. Li, H.M. Zhu, R.Y. Shi, J. Mo, A.Y. Xun, C.H. Jia, J.L. Feng, L.S. Wang, W.S. Zeng, and L. Liu Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum Mol Pharm 8 2 2011 488 497
20. Y.F. Wang, X.Y. Wang, Z. Ren, C.W. Qian, Y.C. Li, K. Kaio, Q.D. Wang, Y. Zhang, L.Y. Zheng, J.H. Jiang, C.R. Yang, Q. Liu, and Y.J. Zhang Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis Antiviral Res 84 2 2009 150 158
21. Q. Deng, W. Zeng, and Z. Yu Signal peptide of Arabinosidase enhances secretion of interferon-alpha2b protein by Bifidobacteria longum Arch Microbiol 191 9 2009 681 686
22. J. Yuan, M. Yu, Q.W. Lin, A.L. Cao, X. Yu, J.H. Dong, J.P. Wang, J.H. Zhang, M. Wang, H.P. Guo, X. Cheng, and Y.H. Liao Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis J Immunol 185 7 2010 4004 4010
23. R. Dennert, H.J. Crijns, and S. Heymans Acute viral myocarditis Eur Heart J 29 2008 2073 2082